Predict your next investment

applichem.us

See what CB Insights has to offer

About AppliChem

AppliChem is a biotechnology company focused on providing animal serum and biological reagents for R&D in cell biology and immonology.

AppliChem Headquarter Location

5710F.St

Omaha, Nebraska, 68117,

United States

402-731-9300

Latest AppliChem News

US Treasury Fines German Chemical Company for Violating Cuba Embargo

Feb 15, 2019

Sputnik International © AFP 2018 / PAUL J. RICHARDS WASHINGTON (Sputnik) - The US government has fined a German chemical firm for selling reagents to Cuba in violation of sanctions, the Treasury Department said in a press release. "The US Department of the Treasury’s Office of Foreign Assets Control (OFAC) today announced a $5,512,564 penalty against AppliChem GmbH ("AppliChem") of Darmstadt, Germany", the release said on Thursday. "AppliChem violated… Cuban Assets Control Regulations when it fulfilled Cuba orders of chemical reagents on 304 invoices". AppliChem’s US parent corporation voluntarily self-disclosed the violations, the release said. OFAC ruled that the infractions constituted "an egregious case", according to the Treasury Department. Following the victory of the Cuban revolutionaries over the US-backed regime in 1959, Washington severed diplomatic ties with Cuba and imposed a trade embargo on the country. In 2014, Washington and Havana expressed their intention to start working on normalizing bilateral relations. As a result, many restrictions on exchanges between the United States and Cuba were eased under then President Barack Obama. In June 2017, US President Donald Trump reversed the policy of his predecessor and abandoned attempts to normalize relations with Havana. Since then, Trump has set new limits for US citizens traveling to Cuba, and banned payments to a military-linked organization that controls the island's tourist industry.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.